BRIEF-Selecta Biosciences commences dosing in Phase 1 clinical trial of nicotine vaccine for smoking cessation and relapse prevention
May 11 Selecta Biosciences Inc
* Selecta Biosciences commences dosing in Phase 1 clinical trial of nicotine vaccine for smoking cessation and relapse prevention Source text for Eikon: Further company coverage:
Israel's Elbit Systems gets $390 mln electronic intelligence deal
TEL AVIV, May 28 Israeli defence electronics company Elbit Systems said on Sunday it won a $390 million contract to supply ground electronic intelligence systems to a European country.
UPDATE 1-Greece's Energean to supply 23 bcm of gas to Israeli power stations
JERUSALEM, May 28 Greece's Energean said on Sunday it signed contracts to supply up to 23 billion cubic meters of natural gas to private Israeli power stations from the Tanin and Karish gas fields offshore Israel.